Google unveils Gemini 3 claiming the lead in math, science, multimodal and agentic AI benchmarks

After more than a month of rumors and feverish speculation — including Polymarket wagering on the release date — Google today ...

Vertex’s CEO was an AI skeptic. But not anymore.

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...
AI Business

Google Intros New Vertex AI Agent Builder Tools

Google Cloud introduced updates to its Vertex AI Agent Builder on Wednesday, providing enterprises with more ways to build, ...

Google’s Gemini 3 AI model makes its long-awaited debut, crushing rivals on top benchmarks

The launch of Gemini 3 has been hotly anticipated for several months, and Google is doing everything it can to ensure that ...

OpenText Deepens Partnership with Google to Accelerate AI Innovation, Data Security, and Sovereign Cloud Solutions

OpenText™ (NASDAQ/TSX: OTEX), a global leader in secure information management for AI, today announced an expanded partnership with Google Cloud to deliver transformative solutions across artificial ...

Ticketek Introduces 'Stella': A Revolutionary Chatbot Powered by Google's Vertex AI

Powered by Google Cloud’s Vertex AI, Stella marks the first tangible outcome of a strategic partnership between Ticketek Entertainment Group (TEG) and Google Cloud. The chatbot is designed to learn ...

Goldman Sachs Remains Bullish on Vertex (VERX) After Q3 2025 Results

Vertex, Inc. (NASDAQ:VERX) experienced a price target cut on November 5, 2025, with Goldman Sachs lowering its target from ...

Google is flexing its biggest advantage over OpenAI with Gemini 3

Google has spent three years trying to get its "full stack" working in harmony. With Gemini 3, it might have just done that.

Vertex CEO's Transformation: From AI Skeptic to Advocate in Drug Discovery

In recent years, the conversation around artificial intelligence (AI) in healthcare has intensified, especially in the realm of drug discovery. Reshma Kewalramani, the CEO of Vertex Pharmaceuticals, ...